Abstract
BACKGROUND: Pancreatic antibodies occur in about one third of patients with Crohn's disease. AIMS: To evaluate the relevance of pancreatic antibodies as a genetic marker in patients with Crohn's disease and their first degree family members and spouses. To characterise further pancreatic antibodies by assessment of IgG subclasses. METHODS: Six hundred and fifty serum samples were tested for pancreatic antibodies by immunofluorescence on sections of human pancreas. Incidence of pancreatic antibodies and their subtypes were studied on 212 serum samples from patients with Crohn's disease. In the familial study, 72 patients with Crohn's disease and 196 first degree family members and 26 patients with ulcerative colitis and 90 first degree family members were included. Ten healthy families served as controls. RESULTS: Pancreatic antibodies were found in 58 (27%) of the patients with Crohn's disease and in none of the controls. Thirty patients had pancreatic antibodies of subtype I characterised by a drop-like fluorescence in the pancreatic acini, 28 patients had subtype II with a fine speckled staining in the acinar cells. Pancreatic antibodies of subtype I were both IgG1 and IgG2 antibodies by contrast with subtype II which were mainly of IgG1 subclass. Only five of 196 first degree relatives of patients with Crohn's disease had pancreatic antibodies. Four of these people had anamnestic data compatible with inflammatory bowel disease. Further investigations showed Crohn's disease in two of these people. In families with more than one member positive for pancreatic antibodies, pancreatic antibodies were of the same subtype in all cases. CONCLUSIONS: Pancreatic antibodies are a specific marker for Crohn's disease. Two subgroups of pancreatic antibodies can be distinguished by their pattern and immunoglobulin subclasses. Pancreatic antibodies rarely occur in family members of patients with Crohn's disease. These family members may also have Crohn's disease.
Full text
PDF



Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berberian L. S., Valles-Ayoub Y., Gordon L. K., Targan S. R., Braun J. Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis. J Immunol. 1994 Oct 15;153(8):3756–3763. [PubMed] [Google Scholar]
- Farmer R. G. Study of family history among patients with inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:64–68. doi: 10.3109/00365528909091355. [DOI] [PubMed] [Google Scholar]
- Lee J. C., Lennard-Jones J. E., Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology. 1995 Feb;108(2):428–433. doi: 10.1016/0016-5085(95)90070-5. [DOI] [PubMed] [Google Scholar]
- Lewkonia R. M., McConnell R. B. Progress report. Familial inflammatory bowel disease--heredity or environment? Gut. 1976 Mar;17(3):235–243. doi: 10.1136/gut.17.3.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malchow H., Ewe K., Brandes J. W., Goebell H., Ehms H., Sommer H., Jesdinsky H. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984 Feb;86(2):249–266. [PubMed] [Google Scholar]
- Mayberry J. F., Rhodes J., Newcombe R. G. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J. 1980 Jan 12;280(6207):84–84. doi: 10.1136/bmj.280.6207.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orholm M., Munkholm P., Langholz E., Nielsen O. H., Sørensen T. I., Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991 Jan 10;324(2):84–88. doi: 10.1056/NEJM199101103240203. [DOI] [PubMed] [Google Scholar]
- Saxon A., Shanahan F., Landers C., Ganz T., Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990 Aug;86(2):202–210. doi: 10.1016/s0091-6749(05)80067-3. [DOI] [PubMed] [Google Scholar]
- Seibold F., Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1994 Aug;107(2):532–536. doi: 10.1016/0016-5085(94)90181-3. [DOI] [PubMed] [Google Scholar]
- Seibold F., Weber P., Jenss H., Wiedmann K. H. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut. 1991 Oct;32(10):1192–1197. doi: 10.1136/gut.32.10.1192. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seibold F., Weber P., Klein R., Berg P. A., Wiedmann K. H. Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut. 1992 May;33(5):657–662. doi: 10.1136/gut.33.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shanahan F., Duerr R. H., Rotter J. I., Yang H., Sutherland L. R., McElree C., Landers C. J., Targan S. R. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology. 1992 Aug;103(2):456–461. doi: 10.1016/0016-5085(92)90834-l. [DOI] [PubMed] [Google Scholar]
- Stöcker W., Otte M., Ulrich S., Normann D., Finkbeiner H., Stöcker K., Jantschek G., Scriba P. C. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scand J Gastroenterol Suppl. 1987;139:41–52. doi: 10.3109/00365528709089774. [DOI] [PubMed] [Google Scholar]
- TRUELOVE S. C., WITTS L. J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955 Oct 29;2(4947):1041–1048. doi: 10.1136/bmj.2.4947.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weterman I. T., Peña A. S. Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology. 1984 Mar;86(3):449–452. [PubMed] [Google Scholar]
- Weterman I. T., Peña A. S. Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology. 1984 Mar;86(3):449–452. [PubMed] [Google Scholar]
- Yang H., McElree C., Roth M. P., Shanahan F., Targan S. R., Rotter J. I. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut. 1993 Apr;34(4):517–524. doi: 10.1136/gut.34.4.517. [DOI] [PMC free article] [PubMed] [Google Scholar]


